Press Releases

SAN FRANCISCO, Sept. 12, 2019 /PRNewswire/ -- Catalia Health and Pfizer today announced they have launched a pilot program to explore patient behaviors outside of clinical environments and to test the impact regular engagement with artificial intelligence (AI) has on patients' treatment journeys. The 12-month pilot uses the Mabu® Wellness Coach, a ro

TORONTO, Sept. 12, 2019 /PRNewswire/ -- PointClickCare has been named to the Forbes 2019 Cloud 100, the definitive ranking of the top 100 private cloud companies in the world, published by Forbes in partnership with

NEW YORK, Sept. 12, 2019 /PRNewswire/ -- The emergency room (ER) is the default choice for most Americans when they need medical care. Nearly 3 in 4 Americans (73%) think it is easier to go to the ER than to get a doctor's appointment, according to a new independent study from Zocdoc.

SHELTON, Conn., Sept. 12, 2019 /PRNewswire/ -- NanoViricides, Inc. (NYSE Amer.: NNVC) (the "Company"), announced today that its Board of Directors has approved a 1-for-20 reverse split of all of the Company's capital stock, including its common stock, which will be effective after the market closes on September 23, 2019. The common sto

VERONA, Italy, Sept. 12, 2019 /PRNewswire/ -- CROMSOURCE, an international contract research organization (CRO), has announced consolidation of its Hybrid Services Model.  Due to client demand, CROMSOURCE has further refined its Hybrid Services to be able to provide its pharmaceutical, medical device, and biotechnology clients with an efficient alternative to

SAN DIEGO, Sept. 12, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) ("the Company"), the first-ever publicly traded cannabis company in the United

MARINA DEL REY, Calif., Sept. 12, 2019 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (the "Company" or "Armata"), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that the Company has developed a new synthetic phage candidate targeting the pathog

THOUSAND OAKS, Calif., Sept. 12, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that new data from its oncology portfolio and pipeline will be presented at the 17th International Myeloma Workshop (IMW) 2019 in Boston, Sept. 12-15, 2019. Data featured from Amgen's hematology f

TORONTO, Sept. 12, 2019 /PRNewswire/ -- Mircom is pleased to announce today its launch of the new FX-3318 Single Loop Intelligent Addressable Panel, available for purchase in UL markets only.The FX-3318 is UL 864 9th Edition listed and has COA (New York) and CSFM (California) listin

NEW YORK, Sept. 12, 2019 /PRNewswire/ -- As part of its mission to provide the Parkinson's community with high-quality resources on every aspect of the disease, The Michael J. Fox Foundation for Parkinson's Research (MJFF) today launches "Navigating Cognitive Changes in Parkinson's Disease." The new guide, available at